GlassScriptPhysician profile
Thu Thien Pham
NPI 1770760340
$2,973.19
in general payments reported to CMS, 2019-2025
21 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $125 · 2021: $190 · 2022: $276 · 2023: $407 · 2024: $848 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $965.48 | 2019-2025 | Hydrus Microstent, Clareon, Lensx |
| Tarsus Pharmaceuticals, INC. | $344.48 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $239.16 | 2019-2025 | Cequa |
| Abbvie INC. | $217.33 | 2022-2025 | |
| New World Medical,INC. | $150.98 | 2023-2024 | Clearpath, Streamline, Kahook Dual Blade |
| Oyster Point Pharma, INC. | $145.99 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Rxsight INC | $140.95 | 2022-2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Bausch & Lomb Americas INC. | $138.69 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Sight Sciences, INC. | $94.05 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $89.55 | 2019 | |
| Eyepoint US, INC. | $82.83 | 2021-2022 | |
| Allergan, INC. | $77.40 | 2020-2021 | |
| Harrow Eye, LLC | $72.91 | 2024-2025 | Vevye |
| Dompe US, INC. | $47.48 | 2019-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $44.52 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $32.66 | 2025 | Idosetr |
| Amgen INC. | $24.86 | 2025 | Tepezza |
| Shire North American Group INC | $22.99 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $19.81 | 2022 | |
| Aerie Pharmaceuticals, INC. | $11.11 | 2019 | |
| Lensar, INC. | $9.96 | 2024 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thu Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.